Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III b, Single-arm, Multicenter, Optimal Dose Finding Study to Assess the Efficacy and Safety of P1101 in Japanese Patients With Polycythemia Vera (PV).

NCT06002490 is registered in ClinicalTrials.gov with PharmaEssentia Japan K.K. as lead sponsor.

NCT NCT06002490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06002490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III b, Single-arm, Multicenter, Optimal Dose Finding Study to Assess the Efficacy and Safety of P1101 in Japanese Patients With Polycythemia Vera (PV).
Lead sponsor
PharmaEssentia Japan K.K.
Phase
Phase 3
Overall status
Completed
Start date
October 17, 2023
Completion date
July 26, 2024
Enrollment
21 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

polycythemia vera (pv)